FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078445 [Registered on: 23/12/2024] Trial Registered Prospectively
Last Modified On: 19/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   STUDY ON REDUCING HYPOGLYCEMIA IN HEMODIALYSIS PATIENTS USING CGM AND ITS IMPACT ON COGNITIVE FUNCTION AND CARDIOVASCULAR EVENTS 
Scientific Title of Study   MITIGATING HYPOGLYCEMIA RISKS IN HEMODIALYSIS PATIENTS USING CONTINOUS GLUCOSE MONITORING AND ITS IMPACT ON COGNITIVE FUNCTION,INTRADIALYTIC COMPLICATIONS AND CARDIOVASCULAR EVENTS  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR NANDA KAMAL 
Designation  PG RESIDENT 
Affiliation  BELIEVERS CHURCH MEDICAL COLLEGE 
Address  DEPARTMENT OF GENERAL MEDICINE BELIEVERS CHURCH MEDICAL COLLEGE KUTTAPUZHA THIRUVALLA

Pathanamthitta
KERALA
689103
India 
Phone  9497854565  
Fax    
Email  nandakamal0@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SUNIL ANTONY 
Designation  PROFESSOR 
Affiliation  BELIEVERS CHURCH MEDICAL COLLEGE 
Address  DEPARTMENT OF GENERAL MEDICINE BELIEVERS CHURCH MEDICAL COLLEGE KUTTAPUZHA THIRUVALLA

Pathanamthitta
KERALA
689103
India 
Phone  9497854565  
Fax    
Email  drsunilantony@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SUNIL ANTONY 
Designation  PROFESSOR 
Affiliation  BELIEVERS CHURCH MEDICAL COLLEGE 
Address  DEPARTMENT OF GENERAL MEDICINE BELIEVERS CHURCH MEDICAL COLLEGE KUTTAPUZHA THIRUVALLA

Pathanamthitta
KERALA
689103
India 
Phone  9497854565  
Fax    
Email  drsunilantony@gmail.com  
 
Source of Monetary or Material Support  
DEPARTMENT OF GENERAL MEDICINE BELIEVERS CHURCH MEDICAL COLLEGE,THIRUVALLA 
 
Primary Sponsor  
Name  DR JENCY MARIA KOSHY 
Address  DEPARTMENT OF GENERAL MEDICINE BELIEVERS CHURCH MEDICAL COLLEGE,KUTTAPUZHA,THIRUVALLA,689103 
Type of Sponsor  Other [OTHERS -DEPARTMENT FUND] 
 
Details of Secondary Sponsor  
Name  Address 
DEPARTMENT OF NEPHROLOGYBELIEVERS CHURCH MEDICAL COLLEGE  BELIEVERS CHURCH MEDICAL COLLEGE,KUTTAPUZHA,THIRUVALLA,689103 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR NANDA KAMAL  BELIEVERS CHURCH MEDICAL COLLEGE  DEPARTMENT OF NEPHROLOGY BELIEVERS CHURCH MEDICAL COLLEGE,KUTTAPUZHA,THIRUVALLA,689103
Pathanamthitta
KERALA 
9497854565

nandakamal0@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DEPARTMENT OF GENERAL MEDICINE,INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: N184||Chronic kidney disease, stage 4 (severe),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  CONTINOUS GLUCOSE MONITORING  HEMODIALYSIS PATIENTS WHO ARE DIABETIC AND ON INSULIN AND PATIENT IS FOLLOWED UP FOR 1 YEAR 
Comparator Agent  HEMODIALYSIS PATIENTS  HEMODIALYSIS PATIENTS WHO ARE DIABETIC 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  PATIENT WITH DIABETIC NEPHROPATHY ON HEMODIALYSIS WITH MINIMUM TWICE DIALYSIS WEEKLY 
 
ExclusionCriteria 
Details  PATIENT TAKING STEROIDS
PATIENT WITH PRE EXISTING PSYCHIATRIC ILLNESS  
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
TO REDUCE THE RISK OF HYPOGLYCEMIA IN HEMODIALYSIS PATIENTS USING CGM  1 YEAR 
 
Secondary Outcome  
Outcome  TimePoints 
EVALUATE THE FREQUENCY,SEVERITY AND PATTERN OF HYPOGLYCEMIC EPISODES IN DIALYSIS PATIENTS THROUGH CGM DATA AND APPROPRIATE INTERVENTIONS IF ANY  1 YEAR 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   30/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   THIS IS A STUDY TO REDUCE THE RISK OF HYPOGLYCEMIA IN HEMODIALYSIS PATIENTS USING CGM AND TO ASSESS ITS IMPACT ON COGNITIVE DECLINE AND CARDIAC COMPLICATIONS.THIS STUDY WILL HELP TO REDUCE THE EPISODES OF HYPOGLYCEMIA IN PATIENTS DURING HEMODIALYSIS.THIS STUDY IS TO BE DONE IN DIABETIC NEPHROPATHY PATIENTS WHO ARE ATLEAST TWICE WEEKLY ON HEMODIALYSIS 
Close